Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Cash flows from operating activities:
Net loss	$ (2,820,763)	$ (2,016,932)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense	2,893,658	49,336
Stock-based consulting expense	603,924	268,999
Stock-based 401K company common match	29,705	0
Depreciation expense	93,814	21,415
Loss on disposal of fixed assets related to lease termination	310,951	0
Bargain purchase gain from merger	(11,939,331)	0
Changes in assets and liabilities:
Prepaid expenses and other assets	1,908,520	34,366
Accounts payable	(1,521,516)	244,305
Accrued expenses	(900,622)	146,562
Restructuring reserve	(1,211,939)	0
Net cash used in operating activities	(12,553,599)	(1,251,949)
Cash flows from investing activities:
Cash received in reverse merger transaction	29,106,512	0
Net cash provided by investing activities	29,106,512	0
Cash flows from financing activities:
Payments for capital lease obligation	0	(10,636)
Proceeds from issuance of common stock, net of issuance costs	750,000	1,229,370
Net cash provided by financing activities	750,000	1,218,734
Net increase (decrease) in cash and cash equivalents	17,302,913	(33,215)
Cash and cash equivalents at beginning of period	103,695	175,884
Cash and cash equivalents at end of period	17,406,608	142,669
Cash paid for:
Interest	606	1,022
Supplemental cash flow information:
Conversion of convertible notes and accrued interest into common stock	32,953	0
Consideration in connection with reverse merger transaction	$ 15,793,638	$ 0